Tirelli, C.; Muscato, G.; Alaimo, C.; Di Leo, I.; Mirijaj, S.; Pennisi, F.; Vancheri, C.; Mondoni, M.
Disease Mechanisms and Therapeutic Advances in Idiopathic and Progressive Pulmonary Fibrosis: From Approved Drugs to Emerging Strategies. J. Clin. Med. 2026, 15, 4172.
https://doi.org/10.3390/jcm15114172
AMA Style
Tirelli C, Muscato G, Alaimo C, Di Leo I, Mirijaj S, Pennisi F, Vancheri C, Mondoni M.
Disease Mechanisms and Therapeutic Advances in Idiopathic and Progressive Pulmonary Fibrosis: From Approved Drugs to Emerging Strategies. Journal of Clinical Medicine. 2026; 15(11):4172.
https://doi.org/10.3390/jcm15114172
Chicago/Turabian Style
Tirelli, Claudio, Giuseppe Muscato, Chiara Alaimo, Irene Di Leo, Sara Mirijaj, Francesco Pennisi, Carlo Vancheri, and Michele Mondoni.
2026. "Disease Mechanisms and Therapeutic Advances in Idiopathic and Progressive Pulmonary Fibrosis: From Approved Drugs to Emerging Strategies" Journal of Clinical Medicine 15, no. 11: 4172.
https://doi.org/10.3390/jcm15114172
APA Style
Tirelli, C., Muscato, G., Alaimo, C., Di Leo, I., Mirijaj, S., Pennisi, F., Vancheri, C., & Mondoni, M.
(2026). Disease Mechanisms and Therapeutic Advances in Idiopathic and Progressive Pulmonary Fibrosis: From Approved Drugs to Emerging Strategies. Journal of Clinical Medicine, 15(11), 4172.
https://doi.org/10.3390/jcm15114172